16 May 2024
Latham & Watkins Advises Verona Pharma in US$650 Million Strategic Financing, One of the Largest Life Sciences Financings of 2024
Advising firms
Deal team
27 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Elizabeth Oh Lead | Latham & Watkins LLP | Partner | debt facility | Not stated |
| Jekkie Kim Lead | Latham & Watkins LLP | Partner | debt facility | Not stated |
| Haim Zaltzman Lead | Latham & Watkins LLP | Partner | debt facility | Not stated |
| Benjamin Gelfand | Latham & Watkins LLP | Counsel | debt facility | Not stated |
| Tyler Davis | Latham & Watkins LLP | Associate | debt facility | Not stated |
| Alex Bogdon | Latham & Watkins LLP | Associate | debt facility | Not stated |
| Mizuna Sekine | Latham & Watkins LLP | Associate | debt facility | Not stated |
| Michael Sweeney | Latham & Watkins LLP | Associate | debt facility | Not stated |
| Patrick Chew | Latham & Watkins LLP | Associate | debt facility | Not stated |
| Ben Wright | Latham & Watkins LLP | Partner | UK finance matters | Not stated |
| Carry Chen | Latham & Watkins LLP | Associate | UK finance matters | Not stated |
| Rowena McCaughan | Latham & Watkins LLP | Associate | UK finance matters | Not stated |
| Deborah Kirk | Latham & Watkins LLP | Partner | UK intellectual property matters | Not stated |
| Brett Shandler | Latham & Watkins LLP | Associate | UK intellectual property matters | Not stated |
| David Della Rocca | Latham & Watkins LLP | Partner | US ERISA matters | Not stated |
| Nikhil Kumar | Latham & Watkins LLP | Partner | US ERISA matters | Not stated |
| Shaun Thompson | Latham & Watkins LLP | Counsel | UK ERISA matters | Not stated |
| Eric Cho | Latham & Watkins LLP | Partner | tax matters | Not stated |
| Jeremiah Cowen | Latham & Watkins LLP | Associate | tax matters | Not stated |
| Emily Yu | Latham & Watkins LLP | Counsel | security matters | Not stated |
| Reza Mojtabaee-Zamani | Latham & Watkins LLP | Partner | converts matters | Not stated |
| Kevin Zhang | Latham & Watkins LLP | Associate | converts matters | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare regulatory matters | Not stated |
| Eveline Van Keymeulen | Latham & Watkins LLP | Partner | healthcare regulatory matters | Not stated |
| Chad Jennings | Latham & Watkins LLP | Counsel | healthcare regulatory matters | Not stated |
| Jeanne Fabre | Latham & Watkins LLP | Associate | healthcare regulatory matters | Not stated |
| Ranulf Barman | Latham & Watkins LLP | Associate | healthcare regulatory matters | Not stated |
24 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 650m (US$650 million)
- What the figure measures
- Total transaction value
- Client
- Verona Pharma plcBorrower
- Counterparties
- Oaktree Capital Management, L.P. (Lenders)
OMERS Life Sciences (Lenders)